Cardiovascular Systems to Webcast Fiscal 2016 Second-Quarter Earnings Conference Call Thursday, January 21
January 08 2016 - 4:05PM
Business Wire
Live Webcast at 3:45 p.m. CT (4:45 p.m.
ET)
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a
live webcast of its fiscal 2016 second-quarter conference call on
Thursday, January 21, 2016, at 3:45 p.m. CT (4:45 p.m. ET). Scott
Ward, Chairman and Interim President and Chief Executive Officer,
and Larry Betterley, Chief Financial Officer, will discuss the
company’s results for its fiscal second quarter ended December 31,
2015, and its financial outlook. The company will issue a
post-market earnings release prior to the call on January 21.
To access the live webcast, go to the investor section of the
company’s website, www.csi360.com, on the day of the conference
call and click on the webcast icon. A webcast replay will be
available beginning at 6:45 p.m. CT the same day.
To participate in the conference call, dial (877) 201-0168 and
enter 21694741. Please dial in at least 10 minutes prior to the
call.
If you do not have access to the Internet and want to listen to
an audio replay of the conference call, dial (855) 859-2056 and
enter 21694741. The audio replay will be available beginning at
6:45 p.m. CT on Thursday, January 21, 2016, through 10:59 p.m. CT
on Thursday, January 28, 2016.
About Cardiovascular Systems, Inc.Cardiovascular Systems,
Inc., based in St. Paul, Minn., is a medical device company focused
on developing and commercializing innovative solutions for treating
vascular and coronary disease. The company’s Orbital Atherectomy
Systems treat calcified and fibrotic plaque in arterial vessels
throughout the leg and heart in a few minutes of treatment time,
and address many of the limitations associated with existing
surgical, catheter and pharmacological treatment alternatives. The
U.S. FDA granted 510(k) clearance for the use of the Diamondback
Orbital Atherectomy System in peripheral arteries in August 2007.
In October 2013, the company received FDA approval for the use of
the Diamondback Orbital Atherectomy System in coronary arteries. To
date, over 220,000 of CSI’s devices have been sold to leading
institutions across the United States. For more information, visit
the company’s website at www.csi360.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160108005815/en/
Cardiovascular Systems, Inc.Jack Nielsen,
651-202-4919j.nielsen@csi360.comorPadillaCRTMatt Sullivan,
612-455-1709matt.sullivan@padillacrt.com
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jul 2024 to Aug 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Aug 2023 to Aug 2024